Business Description
Ambey Laboratories Ltd
ISIN : INE0M3I01029
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.58 | |||||
Debt-to-EBITDA | 1.24 | |||||
Interest Coverage | 3.02 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.02 | |||||
Beneish M-Score | -3.13 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.87 | |||||
9-Day RSI | 67.65 | |||||
14-Day RSI | 60.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.36 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 56.57 | |||||
Days Sales Outstanding | 21.05 | |||||
Days Payable | 63.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 14.22 | |||||
Operating Margin % | 5.29 | |||||
Net Margin % | 4.36 | |||||
FCF Margin % | 6.06 | |||||
ROE % | 21.4 | |||||
ROA % | 8.05 | |||||
ROIC % | 10.28 | |||||
ROC (Joel Greenblatt) % | 26.13 | |||||
ROCE % | 22.48 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36 | |||||
PE Ratio without NRI | 35.97 | |||||
PS Ratio | 1.57 | |||||
PB Ratio | 6.97 | |||||
Price-to-Tangible-Book | 7.27 | |||||
Price-to-Free-Cash-Flow | 25.91 | |||||
Price-to-Operating-Cash-Flow | 17.43 | |||||
EV-to-EBIT | 22.78 | |||||
EV-to-EBITDA | 16.66 | |||||
EV-to-Revenue | 1.75 | |||||
EV-to-FCF | 27.06 | |||||
Price-to-Graham-Number | 3.41 | |||||
Earnings Yield (Greenblatt) % | 4.38 | |||||
FCF Yield % | 3.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ambey Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1,048.212 | ||
EPS (TTM) (₹) | 1.832 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 60.4 | ||
14-Day ATR (₹) | 2.910319 | ||
20-Day SMA (₹) | 61.855 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (₹) | 56.1 - 97.2 | ||
Shares Outstanding (Mil) | 24.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ambey Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ambey Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Ambey Laboratories Ltd Frequently Asked Questions
What is Ambey Laboratories Ltd(NSE:AMBEY)'s stock price today?
When is next earnings date of Ambey Laboratories Ltd(NSE:AMBEY)?
Does Ambey Laboratories Ltd(NSE:AMBEY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |